NCT06452498 - Preeclampsia Intervention Netherlands | Biotech Hunter

Enrollment

180

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

April 30, 2028

Study Completion Date

July 31, 2028

Conditions

Pre-Eclampsia Onset Less Than 37 WeeksPre-EclampsiaPre-Eclampsia; Complicating PregnancyPre-Eclampsia as Antepartum ConditionPre-eclampsia or Eclampsia With Pre-existing HypertensionPre-Eclampsia; Affecting FetusHELLP Syndrome Complicating PregnancyHELLP SyndromeHELLP

Interventions

DRUG

Metformin Hydrochloride

Metformin Hydrochloride encapsulated immediate-release tablet of 500 mg, backfilled with cellulose.

DRUG

Placebo

Capsule filled with cellulose.

All Listed Sponsors

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Amsterdam UMC

OTHER